The abovementioned metabolic factors are closely related to insulin resistance and hyperinsulinemia, which activate insulin receptor signaling via the phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways, resulting in metabolic disbalance and disrupted hepatocyte cell cycle control (Figure 1). The gene discussed is INSR; the disease is hyperinsulinism.